Safety and Activity of the Immune Modulator HE2000 on the Incidence of Tuberculosis and Other Opportunistic Infections in AIDS Patients

Por Stickney, Dwight R., Noveljic, Zoja, Garsd, Armando, Destiche, Daniel A., Frincke, James M.
Publicado em 2007

Virological responses of treatment-naïve stage CDC-2 HIV-1 positive subjects receiving VGV-1 injections in a blinded, placebo-controlled, multi-centre clinical trial

Por Noveljic, Zoja, Zhabilov, Harry, Hwang, Jimmy, Clark, Anel, Louw, AnneRika, Wright, Timothy, Bouic, Patrick
Publicado em 2006